There is a resurgence, some say renaissance, of clinical research on psychedelic
substances after decades of dormancy. Recent studies have produced findings suggesting
psychedelics may demonstrate substantial efficacy for serious psychiatric conditions such as
mood and substanceusedisorders. Asaresult, ongoingclinicaltrials with the psychedelic
psilocybin have been given the Breakthrough Therapy designation by the US Food and
Drug Administration that could result in medical approval for major depressive disorder …

There is a resurgence, some say renaissance, of clinical research on psychedelic
substances after decades of dormancy. Recent studies have produced findings suggesting
psychedelics may demonstrate substantial efficacy for serious psychiatric conditions such as
mood and substanceusedisorders. Asaresult, ongoingclinicaltrials with the psychedelic
psilocybin have been given the Breakthrough Therapy designation by the US Food and
Drug Administration that could result in medical approval for major depressive disorder …